Gene · 3693
Papers1,722
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,722
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment Of Endometrial Integrin Beta 5 In Women With Unexplained Recurrent Pregnancy Loss. | J Pak Med Assoc | 2023 | 37482842 | PubTator, text mining | PubMed |
| Retraction Note: Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability. | J Exp Clin Cancer Res | 2023 | 37468933 | PubTator, text mining | PubMed |
| Talin2 and KANK2 functionally interact to regulate microtubule dynamics, paclitaxel sensitivity and cell migration in the MDA-MB-435S melanoma cell line. | Cell Mol Biol Lett | 2023 | 37460977 | PubTator, text mining | PubMed |
| Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer. | Front Cell Dev Biol | 2023 | 37457288 | PubTator, text mining | PubMed |
| Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin. | Cells | 2023 | 37443817 | PubTator, text mining | PubMed |
| Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment. | Theranostics | 2023 | 37441594 | PubTator, text mining | PubMed |
| Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis. | BMC Endocr Disord | 2023 | 37415174 | PubTator, text mining | PubMed |
| Emerging diversity in extracellular vesicles and their roles in cancer. | Front Oncol | 2023 | 37397375 | PubTator, text mining | PubMed |
| Systems crosstalk between antiviral response and cancerous pathways via extracellular vesicles in HIV-1-associated colorectal cancer. | Comput Struct Biotechnol J | 2023 | 37389186 | PubTator, text mining | PubMed |
| A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 37383389 | PubTator, text mining | PubMed |
| The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? | Cancers (Basel) | 2023 | 37370771 | PubTator, text mining | PubMed |
| Facioscapulohumeral Muscular Dystrophy is Associated With Altered Myoblast Proteome Dynamics. | Mol Cell Proteomics | 2023 | 37353005 | PubTator, text mining | PubMed |
| The molecular mechanism of CD81 antibody inhibition of metastasis. | Proc Natl Acad Sci U S A | 2023 | 37339209 | PubTator, text mining | PubMed |
| A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer. | BMC Med Genomics | 2023 | 37337170 | PubTator, text mining | PubMed |
| Modulation of the Endomembrane System by the Anticancer Natural Product Superstolide/ZJ-101. | Int J Mol Sci | 2023 | 37298526 | PubTator, text mining | PubMed |
| A Novel Gene List Identifies Tumors with a Stromal-Mesenchymal Phenotype and Worse Prognosis in Gastric Cancer. | Cancers (Basel) | 2023 | 37296997 | PubTator, text mining | PubMed |
| ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis. | Funct Integr Genomics | 2023 | 37270717 | PubTator, text mining | PubMed |
| Organoid-based single-cell spatiotemporal gene expression landscape of human embryonic development and hematopoiesis. | Signal Transduct Target Ther | 2023 | 37264003 | PubTator, text mining | PubMed |
| Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma. | Discov Oncol | 2023 | 37243813 | PubTator, text mining | PubMed |
| Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation. | Ann Hematol | 2023 | 37233774 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3693/papers?page=9